CORCEPT THERAPEUTICS (CORT) Covered Calls

CORCEPT THERAPEUTICS covered calls Corcept Therapeutics Incorporated is pharmaceutical company, engaged in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders.

You can sell covered calls on CORCEPT THERAPEUTICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CORT (prices last updated Fri 4:16 PM ET):

CORCEPT THERAPEUTICS (CORT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
12.92 +0.42 12.90 13.14 1.6M 10 1.5B
Covered Calls For CORCEPT THERAPEUTICS (CORT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 13 0.85 12.29 5.8% 58.8%
Nov 16 13 1.55 11.59 12.2% 48.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Corcept Therapeutics, Inc. is engaged in the development of drugs for the treatment of severe psychiatric, neurological and metabolic disorders in the United States. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. The company's products include korlym, cushing's syndrome, CORT 108297 and weight gain mitigation. Corcept Therapeutics was founded by David B. Singer and Joseph K. Belanoff On May 13, 1998 by and is headquartered in Menlo Park, CA.